Physician profile
Jimmy Van
NPI 1396032355
$2,858.78
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,196 · 2020: $575 · 2021: $780 · 2022: $269 · 2023: $38.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $752.00 | 2019-2022 | |
| Integra Lifesciences Corporation | $552.27 | 2019-2021 | |
| Smith+Nephew, INC. | $409.78 | 2019-2021 | |
| Royal Biologics, INC. | $319.68 | 2019-2020 | |
| Amgen INC. | $173.87 | 2021-2022 | |
| Orthofix Medical, INC. | $136.11 | 2019 | |
| Acumed LLC | $133.43 | 2022-2023 | |
| Stryker Corporation | $117.34 | 2021 | |
| Derma Sciences, INC. | $102.31 | 2019 | |
| Wright Medical Technology, INC. | $85.56 | 2019 | |
| Mallinckrodt Enterprises LLC | $32.12 | 2019 | |
| Melinta Therapeutics, LLC | $25.04 | 2019 | |
| Depuy Synthes Sales INC. | $19.27 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.